Join Thousands of Industry Leaders and Stay Up to Date With Pharma and Medical Device News
October 3, 2022
Join thousands of industry leaders who receive the NSF pharma biotech or medical device/IVD newsletters each month.
The NSF pharmaceutical and medical device/IVD newsletters are read by thousands of industry executives every month. We cover the latest developments from regulators around the globe as well as information about new draft guidelines, changes to legislation, and issues impacting the industry.
Recent stories covered in the newsletters included:
- The Annex 1 Revision of EU GMP.
- Risk management plans to mitigate drug shortages.
- The build up to IVDR and its implementation.
- FDA guidance on conducting remote regulatory assessments.
- Issues encountered by device manufacturers in the post-Covid-19 world.
Both newsletters feature helpful articles on issues such as compliance, auditing, remediation, regulatory affairs, clinical trials, and other areas.
You can sign up to receive the newsletters by completing your details below.
Subscribe to Our Monthly Newsletters
Complete your details below to receive the newsletter.
Share this Article
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Certifies Johnson Screens as the First Client in India to NSF/ANSI/CAN 61 for PVC Pipes
December 30, 2024Certification of NSF/ANSI/CAN 61 demonstrates compliance to the health effects standard for drinking water system components.
Read the Story
NSF Certifies Aliaxis as the First Client in India to NSF/ANSI/CAN 61 for Polyethylene Fittings
December 30, 2024Certification of NSF/ANSI/CAN 61 demonstrates compliance to the health effects standard for drinking water system components.
Read the Story
Brooklands New Media’s Publication On NSF’s Global Animal Wellness Standards (GAWS) Not Endorsed by NSF
November 25, 2024NSF is aware that a firm called Brooklands New Media plans to publish a book to mark the 5th anniversary of NSF Global Animal Wellness Standards (GAWS).
Read the Story